SCHEMBL1709684

SCHEMBL1709684

CCN(CC)CCCS(=O)(=O)N[C@H](CCc1ccccc1)c1nc(CNCC2CC2)n[nH]1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 1/20 0.62
CCR4 P51679 1/20 0.34
MCHR1 Q99705 2/20 0.33
ADRA2A P08913 2/20 0.33
NPY5R Q15761 1/20 0.33
F11 P03951 1/20 0.33
KLKB1 P03952 1/20 0.33
GAA P10253 1/20 0.33
NAPEPLD Q6IQ20 3/20 0.33
ALDH1A1 P00352 2/20 0.33
TSHR P16473 1/20 0.33
SCN1A P35498 1/20 0.33
SCN2A Q99250 1/20 0.33
SCN3A Q9NY46 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
CACNA2D1 P54289 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1709649 0.90 GHSR (0.68) GHSRCCR4ADRA2AGAAALDH1A1
SCHEMBL10121851 0.88 GHSR (0.56) GHSRGAANAPEPLDALDH1A1
SCHEMBL10121964 0.87 GHSR (0.69) GHSRCCR4ADRA2AGAAALDH1A1
SCHEMBL1709682 0.87 GHSR (0.62) GHSRCCR4ADRA2AGAAALDH1A1
SCHEMBL1709719 0.86 GHSR (0.61) GHSRCCR4ADRA2AALDH1A1TSHR
SCHEMBL1709708 0.86 GHSR (0.67) GHSRCCR4ADRA2AGAAALDH1A1
SCHEMBL1709615 0.86 GHSR (0.61) GHSRCCR4ADRA2AGAAALDH1A1
SCHEMBL10121684 0.86 GHSR (0.59) GHSRCCR4GAATSHRSCN1A
SCHEMBL10122103 0.86 GHSR (0.65) GHSRCCR4ADRA2AGAAALDH1A1
SCHEMBL10121849 0.85 GHSR (0.62) GHSRCCR4ADRA2AGAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120088747-A1 SULFONAMIDE CONTAINING COMPOUNDS AND USES THEREOF ELIXIR PHARMACEUTICALS, INC. 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088747-A1 SULFONAMIDE CONTAINING COMPOUNDS AND USES THEREOF GHSR, GHRHR, STS GHSR 1/4885CCR4 3489/4885MCHR1 378/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.